Literature DB >> 19694825

Guanylyl cyclase C is a specific marker for differentiating primary and metastatic ovarian mucinous neoplasms.

Vincenzo Ciocca1, Alessandro Bombonati, Juan P Palazzo, Stephanie Schulz, Scott A Waldman.   

Abstract

AIMS: The aim was to assess the value of GCC in distinguishing primary ovarian mucinous neoplasms from metastatic mucinous adenocarcinomas with ovarian involvement. Guanylyl cyclase C (GCC) is a brush border membrane receptor for the endogenous peptides guanylin and uroguanylin, and the homologous diarrhoeagenic bacterial heat-stable enterotoxins that is selectively expressed by epithelial cells from the duodenum to the rectum, but not by normal epithelia of the stomach or oesophagus, or normal extramucosal cells in humans. METHODS AND
RESULTS: Fifty ovarian tumours: 27 primary ovarian mucinous neoplasms (seven cystadenomas, 10 borderline tumours and 10 cystadenocarcinomas) and 23 metastatic mucinous adenocarcinomas with ovarian involvement [13 colorectal adenocarcinomas, four gastric adenocarcinomas, six appendiceal mucinous tumours (four adenocarcinomas, one with neuroendocrine features, and two appendiceal mucinous cystadenomas)] were studied. For primary ovarian mucinous neoplasms, 25 of 27 were negative for GCC. Twelve of 13 cases of colorectal adenocarcinoma (except for one neuroendocrine adenocarcinoma) were positive for GCC. Three of four appendiceal mucinous adenocarcinomas were positive for GCC in both the primary and metastatic tumours (except for one neuroendocrine adenocarcinoma). Two of two appendiceal mucinous cystadenomas were positive for GCC. Of four cases of gastric adenocarcinoma with ovarian involvement, only one (primary tumour) exhibited focal GCC staining.
CONCLUSIONS: GCC is a useful marker for differentiating between primary and secondary ovarian mucinous neoplasms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19694825      PMCID: PMC3140017          DOI: 10.1111/j.1365-2559.2009.03358.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  23 in total

1.  Guanylyl cyclase is a heat-stable enterotoxin receptor.

Authors:  S Schulz; C K Green; P S Yuen; D L Garbers
Journal:  Cell       Date:  1990-11-30       Impact factor: 41.582

2.  Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells.

Authors:  G M Pitari; M D Di Guglielmo; J Park; S Schulz; S A Waldman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

3.  Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7.

Authors:  Russell Vang; Allen M Gown; Lee-Shu-Fune Wu; Todd S Barry; Darren T Wheeler; Anna Yemelyanova; Jeffrey D Seidman; Brigitte M Ronnett
Journal:  Mod Pathol       Date:  2006-09-15       Impact factor: 7.842

4.  Intestine-specific activity of the human guanylyl cyclase C promoter is regulated by Cdx2.

Authors:  J Park; S Schulz; S A Waldman
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

5.  Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.

Authors:  K Shailubhai; H H Yu; K Karunanandaa; J Y Wang; S L Eber; Y Wang; N S Joo; H D Kim; B W Miedema; S Z Abbas; S S Boddupalli; M G Currie; L R Forte
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

6.  Bacterial enterotoxins are associated with resistance to colon cancer.

Authors:  G M Pitari; L V Zingman; D M Hodgson; A E Alekseev; S Kazerounian; M Bienengraeber; G Hajnóczky; A Terzic; S A Waldman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-19       Impact factor: 11.205

7.  The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases.

Authors:  Kenneth R Lee; Robert H Young
Journal:  Am J Surg Pathol       Date:  2003-03       Impact factor: 6.394

8.  CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours.

Authors:  Filippo Fraggetta; Giuseppe Pelosi; Alessia Cafici; Paolo Scollo; Paolo Nuciforo; Giuseppe Viale
Journal:  Virchows Arch       Date:  2003-10-24       Impact factor: 4.064

9.  Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis.

Authors:  Jeffrey D Seidman; Robert J Kurman; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2003-07       Impact factor: 6.394

10.  Binding of Escherichia coli heat-stable enterotoxin to receptors on rat intestinal cells.

Authors:  R A Giannella; M Luttrell; M Thompson
Journal:  Am J Physiol       Date:  1983-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.